NCT06357429

Brief Summary

It is an experimental study conducted to evaluate the effectiveness of cold application to the LI4 point of the hand to reduce/eliminate pain, nausea and anxiety in postoperative patients. The population of the study consisted of 116 individuals who underwent abdominal surgery with the open surgery method in a state hospital between February 2022 and November 2022 and were followed up in the inpatient ward. The study was completed with 80 individuals constituting the experimental group (n=40) and the control group (n=40). Patient information form, Mcgill Melzack short pain form, Visual Analog Scale, STAI - TX and Cold Application Evaluation Form were used to collect data. Patients in the experimental group underwent cold application with ice cubes for a total of 20 minutes as 2 minutes of cold application and 15 seconds of waiting 4-6 hours after the patient was admitted to the clinic after surgical intervention. Follow-up was performed before cold application, immediately after cold application, 30 minutes after the end of cold application, 1 hour and 2 hours after the end of cold application.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable pain

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 23, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 18, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 18, 2022

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

March 30, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 10, 2024

Completed
Last Updated

April 10, 2024

Status Verified

April 1, 2024

Enrollment Period

9 months

First QC Date

March 30, 2024

Last Update Submit

April 4, 2024

Conditions

Keywords

postoperative paincold applicationLI4anxietynauseaafter surgical

Outcome Measures

Primary Outcomes (4)

  • Pain Level

    Visual Analog Scale - There are numbers from 0 to 10 on the scale consisting of a 10 cm line used horizontally or vertically. The lowest number on the scale, 0, means "No Pain", 1-4 means "Mild Pain", 5-6 means "Moderate Pain" and 7-10 means "Intolerable Pain".

    9 Months

  • Nausea Level

    Visual Analog Scale - There are numbers from 0 to 10 on the scale consisting of a 10 cm line used horizontally or vertically. The lowest number on the scale, 0, indicates "No Nausea", 1-4 indicates "Mild Nausea", 5-6 indicates "Moderate Nausea" and 7-10 indicates "Intolerable Nausea".

    9 Months

  • Anxiety Level

    In the State Anxiety Scale, the answer options collected in four classes are (1) Never, (2) A little, (3) A lot and (4) Completely; the options in the Trait Anxiety Scale are (1) Almost never, (2) Sometimes, (3) Very often and (4) Almost always. There are two types of statements in the scales. These are (1) direct or straight statements and (2) reverse statements. Direct statements express negative emotions, while reversed statements express positive emotions. In direct statements, answers with a value of 4 indicate that anxiety is high. In reversed statements, answers with a value of 1 indicate high anxiety. Items 1, 2, 5, 8, 10, 11, 15, 16, 19 and 20 on the state anxiety scale and items 21, 26, 27, 30, 33, 36 and 39 on the trait anxiety scale are inverted statements. The total score of both scales ranges between 20-80. An increase in the score indicates an increase in the level of anxiety.

    9 Months

  • Sensory characteristics, intensity and impact of pain

    The McGill Pain Scale Short Form consists of three parts. Section One: This section includes 15 descriptive word groups. Of these, 11 assess the sensory and 4 assess the perceptual dimension of pain. These descriptive words are rated on an intensity scale from 0 to 3 (0= none, 1= mild, 2= moderate, 3= severe). In the first part of the scale, a total of 3 pain scores are obtained: sensory pain score, perceptual pain score and total pain score. The sensory pain score was 0-33, the perceptual pain score was 0-12, and the total pain score was 0-45. An increase in the score indicates an increase in pain. Second Part: In the second part of the form, five word groups ranging from "mild pain" to "unbearable pain" were included to determine the severity of the patient's pain. Third Section: In the third part, the patient's current pain intensity was assessed using a visual comparison scale.

    9 Months

Study Arms (2)

cold application

EXPERIMENTAL

The first group consists of the experimental group in which cold application is planned to be applied to the hand LI4 point after surgical intervention

Other: Cold Application

Control

EXPERIMENTAL

The control group in which routine interventions in the clinic are applied.

Other: Cold Application

Interventions

Cold application was applied to the LI4 acupressure point on the patients' hands using an ice battery.

Controlcold application

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Can speak and understand Turkish
  • Does not have any cognitive, affective and verbal problems that prevent them from communicating,
  • No postoperative complications (bleeding, infection, etc.),
  • Underwent surgery with general anesthesia,
  • Standardized analgesia protocol implemented,
  • Women without a physical hand or arm disability will be included.

You may not qualify if:

  • Those with chronic diseases such as diabetes, blood pressure, etc,
  • Allergic to cold,
  • Women with a certain period of intensive care (excluding postoperative care room) follow-up after surgery will not be included in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saglik Bilimleri University

Istanbul, Uskudar, 34674, Turkey (Türkiye)

Location

MeSH Terms

Conditions

PainNauseaAnxiety DisordersPain, Postoperative

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, DigestiveMental DisordersPostoperative ComplicationsPathologic Processes

Study Officials

  • Ayşegül ALİOĞULLARI, PhD Student

    Saglik Bilimleri Universitesi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PHD Student

Study Record Dates

First Submitted

March 30, 2024

First Posted

April 10, 2024

Study Start

February 23, 2022

Primary Completion

November 18, 2022

Study Completion

November 18, 2022

Last Updated

April 10, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations